General Surgery
Gastroenterology
General Practice
High Evidence
Peer reviewed

Anal Fissure

An anal fissure is a longitudinal tear in the squamous epithelium (anoderm) of the anal canal, extending from the dentat... FRCS exam preparation.

Updated 9 Jan 2026
Reviewed 17 Jan 2026
39 min read
Reviewer
MedVellum Editorial Team
Affiliation
MedVellum Medical Education Platform

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Lateral fissure location — consider Crohn's disease, HIV, tuberculosis, malignancy
  • Multiple fissures — secondary cause likely
  • Severe pain preventing examination — may need EUA
  • Non-healing despite treatment — biopsy to exclude malignancy

Exam focus

Current exam surfaces linked to this topic.

  • FRCS

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Crohn's Disease
  • Anal Cancer

Editorial and exam context

Reviewed by MedVellum Editorial Team · MedVellum Medical Education Platform

Credentials: MBBS, MRCP, Board Certified

FRCS
Clinical reference article

Anal Fissure

1. Clinical Overview

Summary

An anal fissure is a longitudinal tear in the squamous epithelium (anoderm) of the anal canal, extending from the dentate line to the anal verge, most commonly located at the posterior midline. [1,2] It represents one of the most common anorectal conditions causing severe pain and rectal bleeding, affecting approximately 11% of the general population during their lifetime. [3] The condition is characterised by an exquisitely painful tearing sensation during and after defecation, classically described as "passing broken glass," accompanied by bright red bleeding on wiping.

Fissures are classified as acute (symptoms less than 6 weeks, superficial tear with clean edges) or chronic (symptoms > 6-8 weeks, with the characteristic triad of deep ulcer with exposed internal anal sphincter fibres, sentinel pile externally, and hypertrophied anal papilla proximally). [1,4] The pathophysiology centres on internal anal sphincter (IAS) hypertonia leading to ischaemia, particularly at the relatively avascular posterior midline where blood flow is most compromised. [5,6]

Management follows a stepwise approach: conservative measures (fibre, fluids, stool softeners, sitz baths) for acute fissures; pharmacological sphincter relaxation (topical GTN, diltiazem, or nifedipine) for chronic fissures; and surgical intervention (lateral internal sphincterotomy) for medically refractory cases. [1,7] Recognition of atypical fissures (lateral position, multiple, painless) is critical as these require investigation for secondary causes including Crohn's disease, tuberculosis, HIV, syphilis, and malignancy. [8,9]

Key Facts

FeatureDetails
DefinitionLongitudinal tear in anoderm distal to dentate line
Lifetime Prevalence10-11% of general population [3]
Peak Age20-40 years; bimodal (young adults, elderly)
Sex DistributionEqual in young adults; anterior fissures more common in women
LocationPosterior midline 85-90%; Anterior midline 10-15% (25% in women) [1,10]
Classic SymptomSevere tearing pain during/after defecation + bright red blood
Acute vs Chronicless than 6 weeks vs > 6-8 weeks; chronic has triad features
First-Line Medical RxTopical GTN 0.2-0.4% or Diltiazem 2% BD for 6-8 weeks
Gold-Standard SurgeryLateral internal sphincterotomy (> 95% healing) [11]
Critical FindingLateral/atypical fissures = ALWAYS investigate secondary cause

Clinical Pearls

"Posterior Midline Predominance": 85-90% of primary fissures occur at the posterior midline due to poor blood supply in this watershed zone. The posterior commissure receives terminal branches of the inferior rectal artery, creating a relatively ischaemic area vulnerable to trauma and poor healing. [5,6]

"The Vicious Cycle": Fissure → pain → sphincter spasm → elevated resting anal pressure → reduced blood flow → ischaemia → impaired healing → chronic fissure. Breaking this cycle through chemical or surgical sphincter relaxation is the cornerstone of treatment. [5]

"The Chronic Triad": A chronic fissure demonstrates three pathognomonic features visible on examination: (1) deep ulcer with exposed white internal anal sphincter fibres at base, (2) sentinel pile (skin tag) at external margin, (3) hypertrophied anal papilla at proximal margin. [1,4]

"Never Miss Secondary Causes": Lateral fissures, multiple fissures, painless presentation, non-healing despite optimal treatment, or associated perianal disease should prompt investigation for Crohn's disease (most common), tuberculosis, HIV/AIDS, syphilis, or malignancy. [8,9]

"Anterior Fissures in Women": Up to 25% of fissures in women are anterior, often related to obstetric trauma. These have higher rates of surgical failure and incontinence risk with sphincterotomy. [10,12]

Why This Matters Clinically

Anal fissure causes disproportionate suffering relative to its pathological severity. Patients experience severe pain leading to fear of defecation, stool withholding, worsening constipation, and a self-perpetuating cycle of trauma and chronicity. Despite its benign nature, untreated chronic fissures significantly impair quality of life. Accurate diagnosis (usually clinical) and appropriate stepwise management lead to rapid symptom relief and high healing rates. Failure to recognise atypical fissures can delay diagnosis of serious underlying conditions including inflammatory bowel disease and malignancy.


2. Epidemiology

Incidence and Prevalence

MeasureValueSource
Lifetime prevalence10-11%[3]
Annual incidence1.1 per 1,000 person-years[13]
Peak incidence age20-40 years[1,3]
GP consultationsCommon; accounts for 6-15% of proctology referrals[1]
Sex ratioM:F = 1:1 overall; anterior more common in females[10]
Recurrence rate (conservative)30-40%[7]
Recurrence rate (post-LIS)less than 5%[11]

Demographics

FactorDetails
AgeBimodal distribution: young adults (20-40), second peak in elderly; also common in infants (0-1 year)
SexEqual overall; anterior fissures 3x more common in women (25% vs 8% in men)
EthnicityNo significant ethnic variation documented
GeographyMore prevalent in developed countries; associated with Western low-fibre diet
SocioeconomicNo clear association

Risk Factors

Non-Modifiable Risk Factors:

FactorRelative RiskMechanism
Previous anal fissure2-3xScarring, fibrosis, reduced compliance
Childbirth (vaginal)2.5xPerineal trauma, sphincter injury [10]
Instrumental delivery3-4xDirect sphincter damage
Previous anal surgeryVariableAltered anatomy, scarring
Female sex (anterior fissures)3x for anteriorAnatomical: shorter perineal body

Modifiable Risk Factors:

Risk FactorMechanismPrevention Strategy
ConstipationHard stool causes mechanical traumaHigh fibre diet (25-30g/day), adequate fluids
Chronic diarrhoeaChemical irritation, frequent wipingTreat underlying cause, barrier cream
Low fibre dietPromotes hard stoolsDietary modification, fibre supplements
DehydrationContributes to hard stools2-3L fluid daily
Prolonged strainingElevated intra-anal pressure, venous congestionAvoid straining, limit toilet time less than 5 minutes
Anal intercourseDirect mechanical traumaAdequate lubrication
ObesityAssociated constipation, pelvic floor dysfunctionWeight management

Associated Conditions

Primary Associations:

ConditionAssociation TypeClinical Significance
Crohn's diseaseStrongLateral/multiple fissures, fistulae, non-healing; 10-30% of Crohn's patients develop fissures [9]
Ulcerative colitisModerateLess common than Crohn's; posterior predominance preserved
Constipation disordersStrongBoth cause and consequence
Irritable bowel syndromeModerateAltered bowel habit contributes

Secondary/Atypical Fissure Associations:

ConditionFissure CharacteristicsKey Features
HIV/AIDSMultiple, lateral, non-healingConsider CMV, HSV co-infection; CD4 count correlates with healing [14]
TuberculosisChronic, non-healing, multipleRare; consider in endemic areas; biopsy shows caseating granulomas
SyphilisPainless chancre (primary)Serology essential; consider in MSM
Anal carcinomaNon-healing, indurated edgesBiopsy mandatory for non-healing fissures [8]
LeukaemiaPoor healing, infectionNeutropaenia impairs healing
Chemotherapy/immunosuppressionAtypical, non-healingHealing correlates with immune recovery

3. Pathophysiology

Anatomical Basis

Relevant Anatomy of the Anal Canal:

The anal canal is approximately 4cm in length, extending from the anorectal junction to the anal verge. Key anatomical structures relevant to fissure pathophysiology include:

  1. Anoderm: Modified squamous epithelium distal to the dentate line, richly innervated by somatic sensory nerves (inferior rectal nerve) — accounting for the severe pain of fissures
  2. Internal Anal Sphincter (IAS): Smooth muscle; continuation of circular muscle of rectum; involuntary control; responsible for 70-85% of resting anal tone
  3. External Anal Sphincter (EAS): Striated muscle; voluntary control; encircles IAS
  4. Posterior Commissure: Area of anatomical vulnerability where external sphincter fibres diverge, creating a potential weak point

Vascular Anatomy (Critical to Pathophysiology):

The blood supply to the anal canal demonstrates important regional variation: [5,6]

RegionBlood SupplyClinical Significance
Upper anal canalSuperior rectal artery (branch of IMA)Well-perfused
Lower anal canalInferior rectal artery (branch of internal pudendal)Terminal branches; less robust
Posterior midlineWatershed zone; terminal branches of inferior rectalRelatively ischaemic; 85% lower perfusion than lateral quadrants
Anterior midlineSimilar watershed territorySecond most common fissure location
Lateral quadrantsBest perfusionFissures here suggest secondary cause

Exam Detail: Klosterhalfen Angiographic Studies: Seminal work by Klosterhalfen et al. demonstrated that the posterior midline receives significantly reduced blood flow compared to other quadrants. Angiographic studies showed perfusion of the posterior commissure was 85% lower than lateral quadrants. This "watershed zone" theory explains both the posterior predominance of primary fissures and the mechanism of ischaemia-driven poor healing. [5]

Pathophysiological Mechanism

The Ischaemia-Hypertonia Cycle:

The pathophysiology of anal fissure centres on a self-perpetuating cycle of trauma, pain, sphincter spasm, and ischaemia: [5,6,15]

Step 1: Initial Trauma

  • Hard stool passage causes mechanical tear in the anoderm
  • Occurs preferentially at posterior midline (90%) due to:
    • Poorest blood supply (watershed zone)
    • Posterior divergence of external sphincter fibres creates weak point
    • Direction of faecal stream during defecation

Step 2: Pain Response

  • Anoderm is richly innervated with somatic sensory fibres (inferior rectal nerve)
  • Intense sharp pain during and for hours after defecation
  • Pain triggers protective sphincter contraction

Step 3: Internal Anal Sphincter Hypertonia

  • Reflex spasm of IAS in response to pain
  • Mean resting anal pressure elevated to 90-120 mmHg (normal: 40-70 mmHg) [5,15]
  • Hypertonia persists beyond acute pain episode
  • Creates sustained compression of intramural blood vessels

Step 4: Ischaemia and Impaired Healing

  • Elevated IAS tone compresses terminal branches of inferior rectal artery
  • Anodermal blood flow reduced by up to 85% at posterior midline [5]
  • Hypoxic wound environment prevents healing
  • Exposed wound base subject to repeated trauma with each defecation

Step 5: Chronic Fissure Formation

  • Acute fissure fails to heal; becomes chronic (> 6-8 weeks)
  • Development of characteristic chronic triad:
    • "Sentinel pile (skin tag): Oedematous external skin at distal wound margin from chronic inflammation"
    • "Hypertrophied anal papilla: Fibrotic overgrowth at proximal (internal) wound margin"
    • "Exposed sphincter fibres: Deep ulcer exposes white IAS muscle at wound base"
  • Fibrosis develops at wound margins, further impairing healing

Step 6: Cycle Perpetuation

  • Fear of pain leads to stool withholding
  • Constipation worsens; stools become harder
  • Further trauma to unhealed fissure with each defecation
  • Cycle continues until sphincter tone is reduced (medically or surgically)

Exam Detail: Manometric Evidence: Studies consistently demonstrate that patients with chronic anal fissure have significantly elevated maximum resting anal pressure (MRAP) compared to controls:

  • Normal MRAP: 40-70 mmHg
  • Chronic fissure MRAP: 90-120 mmHg
  • After successful treatment (medical or surgical): MRAP normalises
  • This elevated tone is the therapeutic target of all treatments [5,15]

Classification

Temporal Classification:

TypeDurationPathological FeaturesTreatment Approach
Acute Fissureless than 6 weeksSuperficial tear; clean, sharp edges; minimal fibrosis; healthy baseConservative management (fibre, fluids, stool softeners, sitz baths); 50-60% heal spontaneously [7]
Chronic Fissure> 6-8 weeksDeep ulcer; exposed IAS fibres; sentinel pile; hypertrophied papilla; fibrotic edgesMedical therapy (GTN, diltiazem) ± botulinum toxin; surgery if refractory [1]

Aetiological Classification:

TypeLocationCharacteristicsCauses
Primary (Idiopathic)Posterior midline (85-90%) or Anterior midline (10-15%)Single; typical chronic features; associated with IAS hypertoniaConstipation, hard stool trauma, childbirth
SecondaryLateral; off-midline; multipleAtypical features; may be painless; associated pathologyCrohn's disease, HIV, TB, syphilis, malignancy, leukaemia

Location Significance

LocationFrequencyClinical Implications
Posterior midline85-90% males; 75% femalesPrimary fissure; standard management pathway
Anterior midline8-10% males; 20-25% femalesPrimary fissure; higher incontinence risk with surgery; consider obstetric history in women
Lateralless than 2% of primaryALWAYS investigate for secondary cause
MultipleRare in primaryALWAYS investigate — Crohn's disease, HIV, immunosuppression
CircumferentialVery rareSevere Crohn's disease or other IBD; rarely primary

4. Clinical Presentation

Symptoms

Cardinal Symptoms:

SymptomFrequencyCharacteristics
Pain95-100%Severe, sharp, tearing quality; "like passing broken glass"; occurs during defecation and persists for minutes to hours afterwards; may be incapacitating
Bleeding70-80%Bright red blood; on toilet paper or surface of stool; small volume (streaking); rarely significant blood loss
Constipation50-60%Often pre-existing (cause); may worsen due to fear of defecation (consequence)
Pruritus ani20-30%Mild perianal itching between bowel movements; from discharge/moisture
Discharge10-20%Minimal mucoid or serosanguinous; more common in chronic fissures

Symptom Characteristics:

Pain Pattern:

  • Begins with passage of stool through anal canal
  • Sharp, cutting quality during defecation
  • Persists as dull ache or burning for 30 minutes to several hours post-defecation
  • May be so severe patient avoids defecation (exacerbating constipation)
  • Pain-free interval between bowel movements (distinguishes from other conditions)

Bleeding Pattern:

  • Bright red (arterial)
  • Small volume — streaks on toilet paper or surface of stool
  • Occurs with each bowel movement
  • Rarely causes anaemia (consider alternative diagnosis if significant)

Atypical Presentations

PresentationClinical SignificanceLikely Cause
Painless fissureSuggests denervation or secondary causeCrohn's disease, neurological disorder, HIV, diabetes
Lateral locationSecondary cause mandatory to excludeCrohn's (most common), TB, HIV, malignancy, syphilis
Multiple fissuresSecondary cause highly likelyCrohn's disease, HIV/AIDS, immunosuppression
Minimal/no bleedingCan occur with chronic, fibrotic fissuresChronic fissure or secondary cause
Purulent dischargeAssociated abscess or fistulaCrohn's disease, cryptoglandular abscess
Weight loss, systemic symptomsMalignancy or IBDRequires urgent investigation

Signs

Examination Findings (Inspection):

FindingAcute FissureChronic FissureSignificance
FissureSuperficial tear; clean edgesDeep ulcer; exposed white IAS fibresDefines chronicity
Sentinel pileAbsentPresent (external skin tag at distal margin)Indicates chronic fissure
Hypertrophied papillaAbsentPresent (at proximal margin — seen on anoscopy)Indicates chronic fissure
LocationUsually posterior midlineUsually posterior midlineLateral = investigate
Surrounding skinNormalMay show excoriation, dermatitisChronic irritation

Digital Rectal Examination:

  • Often not possible due to severe pain and sphincter spasm
  • If tolerable:
    • High resting tone (hypertonia)
    • Marked tenderness at fissure site
    • Palpable fibrous band (chronic fissure)
    • Exclude rectal mass
  • Important: Do NOT force examination if severe pain — defer or perform under anaesthesia (EUA)

Anoscopy/Proctoscopy:

  • Usually deferred in acute setting due to pain
  • If tolerated (with topical anaesthetic):
    • Visualises fissure directly
    • Identifies hypertrophied papilla at proximal margin
    • Excludes other pathology (haemorrhoids, polyps, masses)
  • May require EUA if pain prohibitive

Red Flags

[!CAUTION] Red Flags Requiring Further Investigation:

Location:

  • Lateral or off-midline fissure → Crohn's disease, HIV, TB, malignancy
  • Multiple fissures → Secondary cause (Crohn's most common)

Symptoms:

  • Painless fissure → Unusual; consider Crohn's, neuropathy, malignancy
  • Systemic symptoms (weight loss, fatigue, night sweats) → IBD, malignancy
  • Fever → Associated abscess, systemic infection

Examination:

  • Indurated or raised edges → Malignancy — biopsy mandatory
  • Associated fistula or abscess → Crohn's disease
  • Multiple skin tags → Crohn's disease
  • Severe pain preventing any examination → May need EUA

Response to Treatment:

  • Non-healing despite 8+ weeks optimal medical therapy → Biopsy to exclude malignancy
  • Recurrent fissures despite treatment → Consider secondary cause

5. Differential Diagnosis

Key Differentials

DiagnosisKey Distinguishing FeaturesInvestigations
HaemorrhoidsPainless bleeding (unless thrombosed); prolapsing tissue; no fissure on inspectionClinical examination; anoscopy
Perianal abscessContinuous throbbing pain (not just defecation-related); swelling; fluctuance; feverExamination; CT/MRI if deep
Anal fistulaPersistent discharge from external opening; may have history of abscessProbe; MRI pelvis
Crohn's diseaseMultiple/lateral fissures; associated GI symptoms; fistulae; "elephant ear" skin tagsColonoscopy; biopsies; inflammatory markers
Anal cancer (SCC)Non-healing ulcer; indurated edges; bleeding; weight lossBiopsy mandatory
Solitary rectal ulcerLower rectal pain; mucus; tenesmus; prolapse historyProctoscopy; biopsy
Proctalgia fugaxSevere episodic rectal pain; no structural lesion; no bleedingClinical diagnosis; normal examination
Perianal herpes (HSV)Vesicles; multiple shallow ulcers; immunocompromised patientViral PCR; serology
Syphilitic chancrePainless ulcer (primary syphilis); MSM risk factorsSyphilis serology; dark-field microscopy
TB (anorectal)Chronic non-healing; endemic region; pulmonary TBBiopsy with AFB; PCR; CXR

Must Not Miss Diagnoses

  1. Anal cancer — Non-healing fissure > 8 weeks despite treatment; indurated edges; irregular ulcer → Biopsy
  2. Crohn's disease — Lateral/multiple fissures; associated fistulae; GI symptoms → Colonoscopy
  3. HIV-related fissures — Atypical features; immunosuppression; poor healing → HIV test
  4. Malignancy — Weight loss; mass; lymphadenopathy → Urgent investigation

6. Investigations

Clinical Diagnosis

For typical primary anal fissures:

  • History and careful inspection are usually diagnostic
  • No routine investigations required if classic presentation
  • Digital rectal examination if tolerated (assess tone, exclude mass)

Indications for Further Investigation

Investigation is required for:

  • Atypical location (lateral, multiple)
  • Non-healing despite optimal treatment (> 8 weeks)
  • Clinical suspicion of secondary cause
  • Systemic symptoms (weight loss, change in bowel habit)
  • High-risk features for malignancy
  • Pre-operative assessment before surgery

Laboratory Investigations

TestPurposeWhen to Order
FBCAnaemia screen; infection; leukaemiaSignificant bleeding; systemic symptoms; non-healing
CRP/ESRInflammatory markersSuspected Crohn's disease or IBD
HIV testImmunodeficiency screenAtypical/lateral/multiple fissures; risk factors
Syphilis serology (RPR/TPHA)Exclude primary chancrePainless ulcer; MSM; risk factors
HbA1cDiabetes (impairs healing)Chronic non-healing; risk factors
Stool culturesExclude infectious diarrhoeaDiarrhoea-associated fissure
Faecal calprotectinIBD screeningSuspected Crohn's or UC

Imaging

ModalityFindingsIndications
Endoanal ultrasoundSphincter anatomy; defects; previous injuryPre-operative assessment for sphincterotomy; women with obstetric history; recurrent fissure
MRI PelvisFistula mapping; sphincter anatomy; perianal inflammationSuspected Crohn's; associated fistula; complex perianal disease
CT abdomen/pelvisExclude abscess; staging if malignancyDeep abscess suspected; malignancy staging

Endoscopy

InvestigationPurposeIndications
AnoscopyVisualise fissure and upper anal canalConfirm diagnosis; visualise papilla; exclude other pathology
ProctoscopyLower rectal examinationExclude rectal pathology
Flexible sigmoidoscopyLeft colon/rectum assessmentSuspected IBD; atypical presentation
ColonoscopyFull colonic assessmentConfirmed/suspected IBD; change in bowel habit; iron deficiency anaemia

Biopsy

Indications for Biopsy:

  • Non-healing fissure after 8+ weeks of optimal medical treatment
  • Atypical location (lateral)
  • Raised, indurated, or irregular edges
  • Clinical suspicion of malignancy
  • Suspected Crohn's disease (may show granulomas)
  • Suspected TB (caseating granulomas, AFB)

Anorectal Physiology (Manometry)

TestPurposeFindings in Fissure
Anorectal manometryMeasure resting and squeeze pressuresElevated resting pressure (90-120 mmHg); normal squeeze pressure
Rectal sensory testingAssess rectal complianceUsually normal

Clinical Use: Manometry is not routinely required but may be useful for:

  • Pre-operative assessment (identify low baseline pressure — incontinence risk)
  • Research purposes
  • Recurrent fissures with failed surgery
  • Assessment of continence pre-operatively in high-risk patients

7. Management

Management Principles

  1. Break the ischaemia-hypertonia cycle — Reduce IAS tone to improve blood flow and healing
  2. Promote soft, painless bowel movements — Prevent further trauma
  3. Stepwise approach — Conservative → Medical → Surgical (increasing efficacy but also risks)
  4. Address underlying cause — Essential for secondary fissures
  5. Informed consent — Especially for surgery (incontinence risk)

Management Algorithm

ACUTE ANAL FISSURE (less than 6 weeks)
           ↓
Conservative Management (8 weeks)
- Dietary fibre 25-30g/day
- Fluids 2-3L/day
- Stool softeners (lactulose/macrogol)
- Sitz baths (warm water 10-15 min post-defecation)
- Topical lidocaine (short-term analgesia)
           ↓
    ┌──────┴──────┐
 Healed        Not Healed
    ↓              ↓
Maintain     Becomes CHRONIC FISSURE
lifestyle    (> 6-8 weeks)
measures            ↓
           Topical Medical Therapy (6-8 weeks)
           GTN 0.2-0.4% OR Diltiazem 2% BD
                    ↓
              ┌─────┴─────┐
           Healed      Not Healed
              ↓            ↓
         Continue     Second-line:
         lifestyle    - Switch agent (GTN ↔ Diltiazem)
         measures     - Botulinum Toxin Injection
                           ↓
                     ┌─────┴─────┐
                  Healed      Still Not Healed
                     ↓            ↓
                 Lifestyle    SURGICAL MANAGEMENT
                 measures     Lateral Internal Sphincterotomy
                              (after counselling re incontinence risk)

Conservative Management (All Patients)

InterventionDetailsEvidence
Dietary fibre25-30g/day; fruits, vegetables, wholegrain; or supplements (ispaghula, psyllium)Softens stool; reduces straining [1,7]
Fluid intake2-3L water/dayPrevents stool hardening
Stool softenersLactulose 15-30mL BD; Macrogol (Movicol) 1-2 sachets dailyOsmotic laxatives preferred [7]
Sitz bathsWarm water soak for 10-15 minutes after defecation; 2-3x dailyRelaxes sphincter; reduces pain; improves blood flow
AnalgesiaOral paracetamol/NSAIDs 30 min before defecation; avoid opioids (constipating)Reduces defecation anxiety
Topical anaestheticsLidocaine gel 2% (short-term only)Temporary pain relief; may mask symptoms
Avoid strainingLimit toilet time less than 5 minutes; do not defer urgeReduces further trauma

Efficacy of Conservative Management:

  • Acute fissures: 50-60% heal with conservative measures alone [7]
  • Chronic fissures: less than 10% heal without pharmacological intervention [1]

Medical Management (Chronic Fissure)

First-Line Topical Agents:

AgentDose/ApplicationMechanismHealing RateSide Effects
GTN 0.2-0.4% (Rectogesic)Apply pea-sized amount to anal margin BD for 6-8 weeksNitric oxide donor → smooth muscle relaxation → IAS relaxation49-68%Headache (20-50%); tolerance; hypotension [7,16]
Diltiazem 2%Apply BD for 6-8 weeksCalcium channel blocker → IAS relaxation65-75%Headache (10-20%); perianal itch; better tolerated than GTN [7,16]
Nifedipine 0.2-0.3%Apply BD for 6-8 weeksCalcium channel blocker → IAS relaxation60-70%Similar to diltiazem; less headache [17]

Exam Detail: Evidence Summary: GTN vs Diltiazem

The Cochrane systematic review by Nelson et al. (2012) analysed 75 RCTs with 5,031 participants. Key findings: [7]

  • GTN 0.4% healed 48.9% of fissures vs 35.5% with placebo (pless than 0.0009)
  • Calcium channel blockers (diltiazem, nifedipine) showed equivalent efficacy to GTN
  • Diltiazem had significantly fewer headaches (10-20% vs 20-50%)
  • All medical therapies had high recurrence rates (30-50% within 1 year)
  • "Medical therapy is marginally better than placebo but far less effective than surgery"

ASCRS Guidelines Recommendation (2023): [1]

  • Topical GTN or calcium channel blockers are first-line for chronic anal fissure (Strong recommendation, moderate-quality evidence)
  • Diltiazem may be preferred due to better tolerability

Application Technique:

  1. Wash hands before and after application
  2. Apply pea-sized amount to external anal margin and lower anal canal
  3. Do NOT insert deeply into anal canal
  4. Apply after defecation and at bedtime (BD)
  5. Continue for full 6-8 week course even if symptoms improve
  6. Warn patient about headache — often improves after first week

Second-Line Medical Therapy:

AgentDose/TechniqueMechanismHealing RateNotes
Botulinum Toxin A (Botox)20-100 units injected into IAS (under local/sedation)Inhibits acetylcholine release → temporary sphincter paralysis65-85%Effect lasts 3-4 months; may repeat; 5-10% temporary incontinence to flatus [11,18]

Botulinum Toxin Injection Details:

  • Dose: 20-100 units (commonly 40-80 units) [18]
  • Site: Injected directly into IAS, typically at two sites (lateral quadrants) to avoid fissure base
  • Onset: 2-3 days; maximum effect at 2-4 weeks
  • Duration: 3-4 months (reversible)
  • Advantages: Avoids permanent sphincterotomy; repeatable
  • Disadvantages:
    • Temporary (recurrence 40-50% at 2 years) [11]
    • Cost of Botox
    • Temporary incontinence to flatus (5-10%)
  • Best candidates: Patients with high incontinence risk; bridge to surgery; patients declining surgery

Exam Detail: Meta-analysis: Botox vs Lateral Sphincterotomy [18]

Sajid et al. (2012) systematic review findings:

  • LIS: 94.8% healing rate
  • Botox: 69.5% healing rate
  • Recurrence: Higher with Botox (25% vs 2%)
  • Incontinence: Similar rates between groups
  • Conclusion: LIS more effective but Botox viable for patients refusing or unsuitable for surgery

Surgical Management

Indications for Surgery:

  1. Failure of medical therapy (> 8-12 weeks of optimised treatment)
  2. Recurrent chronic fissure
  3. Patient preference (informed consent regarding efficacy vs risks)
  4. Severe symptoms affecting quality of life
  5. Intolerance of medical therapy

Lateral Internal Sphincterotomy (LIS):

FeatureDetails
ProcedureDivision of IAS at lateral position (away from fissure) to level of dentate line
ApproachOpen or closed (subcutaneous) technique; similar efficacy
AnaesthesiaLocal + sedation, regional, or general
SettingDay case surgery
Healing rate95-98% [1,11]
Recurrenceless than 5%
Recovery1-2 weeks until full activity

Surgical Technique:

Open Technique:

  1. Patient in lithotomy or left lateral position
  2. Identify intersphincteric groove at lateral position (3 or 9 o'clock)
  3. Make radial incision (1-2cm) over intersphincteric groove
  4. Identify and isolate lower IAS fibres
  5. Divide IAS from lower edge to dentate line (tailored/controlled)
  6. Achieve haemostasis
  7. Close skin with absorbable suture

Closed Technique:

  1. Small stab incision at intersphincteric groove
  2. Insert blade (No. 11 or cataract knife) into intersphincteric plane
  3. Divide IAS under digital guidance
  4. Smaller wound; similar outcomes

Division Length:

  • Tailored sphincterotomy (division to level of fissure apex) reduces incontinence while maintaining efficacy [1]
  • Full sphincterotomy (to dentate line) has highest healing but also highest incontinence rates
  • Modern practice favours tailored approach

Complications of Lateral Internal Sphincterotomy:

ComplicationIncidenceManagement
Minor incontinence (flatus, soiling)8-12%Usually temporary; pelvic floor exercises
Major incontinence (faeces)1-3%Rare; may require further surgery if persistent
Recurrence2-5%Repeat sphincterotomy or alternative procedure
Bleedingless than 5%Usually minor; pressure
Infectionless than 2%Antibiotics; drainage if abscess
Keyhole deformityRareMay affect continence

Pre-operative Assessment for LIS:

  • Endoanal ultrasound: Assess sphincter integrity, identify pre-existing defects
  • Anorectal manometry: Identify low resting tone (higher incontinence risk)
  • Detailed history: Obstetric trauma, previous anal surgery, baseline continence
  • Counsel all patients about permanent incontinence risk

High-Risk Patients for Incontinence:

  • Women (especially multiparous, instrumental delivery)
  • Previous sphincter injury
  • Low baseline resting pressure on manometry
  • Elderly patients
  • Pre-existing minor incontinence symptoms
  • Anterior fissures (avoid anterior sphincterotomy)

Alternative Surgical Procedures:

ProcedureIndicationAdvantagesDisadvantages
FissurectomyChronic fissure with sentinel pileRemoves chronic wound; allows fresh healingDoes not address sphincter hypertonia
Fissurectomy + advancement flapHigh incontinence risk; prior sphincterotomyPreserves sphincter; good healing ratesMore complex; donor site morbidity
Anal advancement flapFailed sphincterotomy; incontinence riskCovers defect with healthy tissueTechnical; variable results
Posterior midline sphincterotomyHistorical; rarely usedDirect access to fissureHigher incontinence; keyhole deformity

Management of Secondary Fissures

Crohn's Disease:

  • Treat underlying Crohn's disease (immunomodulators, biologics)
  • Conservative measures for fissure
  • Avoid sphincterotomy (high failure rate; incontinence risk)
  • Consider Botox if fissure symptomatic and Crohn's controlled
  • Fistula/abscess management may take priority
  • Involve IBD specialist

HIV/AIDS:

  • Optimise antiretroviral therapy (healing correlates with immune reconstitution)
  • Conservative management
  • Avoid surgery if CD4 less than 200 (poor healing)
  • Investigate for opportunistic infections (CMV, HSV)

Tuberculosis:

  • Anti-tuberculous chemotherapy
  • Fissure often heals with systemic treatment
  • Biopsy to confirm diagnosis

Malignancy:

  • Urgent biopsy and staging
  • Oncological treatment (chemoradiation for SCC)
  • Surgical excision if appropriate
  • Multidisciplinary team management

Disposition and Follow-up

SettingRecommendation
Acute fissure (GP)Conservative management; review at 4-6 weeks; refer if not healing
Chronic fissure (GP/Specialist)Medical therapy 8 weeks → surgical referral if failed
Post-medical therapyReview at 8 weeks; assess healing; if healed, maintain lifestyle measures
Post-LISReview at 6 weeks; assess healing and continence
Long-termMaintain high fibre diet; adequate fluids; avoid constipation to prevent recurrence

8. Complications

Complications of Untreated Anal Fissure

ComplicationIncidenceClinical FeaturesManagement
Chronicity40% of untreated acute fissuresPersistent symptoms > 6-8 weeks; chronic triad featuresMedical therapy → surgery
Sentinel pileCommon in chronicExternal skin tag at distal fissure marginExcision if symptomatic; usually with fissure treatment
Anal stenosisRare (less than 5%)Difficulty passing stool; narrowed anal canal; fibrosisAnal dilation; stricturoplasty; flap surgery
Quality of life impairmentVery commonFear of defecation; avoidance behaviours; depressionDefinitive fissure treatment
Chronic constipationCommonStool withholding from painAddress fissure; laxatives
Abscess/fistulaRare (unless Crohn's)New pain; swelling; dischargeSurgical drainage

Complications of Treatment

Medical Therapy Complications:

TreatmentComplicationIncidenceManagement
GTNHeadache20-50%Often improves after 1-2 weeks; reduce dose; switch to CCB
GTNTachyphylaxisVariableDrug holiday; switch agent
GTNHypotensionless than 5%Caution with concurrent nitrates; phosphodiesterase inhibitors contraindicated
DiltiazemHeadache10-20%Reduce dose; switch agent
DiltiazemPerianal itch/dermatitis5-10%Barrier cream; consider alternative
BotoxTemporary incontinence (flatus)5-10%Resolves as effect wears off (3-4 months)
BotoxFailure to heal20-30%Repeat injection or surgery

Surgical Complications (LIS):

ComplicationIncidenceRisk FactorsManagement
Minor incontinence (flatus, soiling)8-12%Obstetric trauma; prior surgery; excessive divisionUsually temporary; pelvic floor exercises; biofeedback
Major incontinence (faeces)1-3%As above; full sphincterotomyMay require repair surgery if persistent
Recurrence2-5%Insufficient division; secondary causeInvestigate; consider repeat surgery
Bleedingless than 5%AnticoagulantsPressure; cautery; rarely exploration
Infectionless than 2%Immunosuppression; diabetesAntibiotics; drainage
Keyhole deformityRarePosterior sphincterotomyAvoid posterior approach
Delayed wound healing5-10%Diabetes; immunosuppression; smokingWound care; optimise risk factors

9. Prognosis and Outcomes

Natural History

  • Acute fissures: 50-60% heal spontaneously within 4-6 weeks with conservative measures alone [7]
  • Untreated acute fissures: ~40% progress to chronic fissures [1]
  • Chronic fissures: Rarely heal spontaneously (less than 10%) due to persistent ischaemia-hypertonia cycle [7]
  • Recurrence: Common if underlying risk factors (constipation, diet) not addressed

Outcomes with Treatment

TreatmentHealing RateRecurrence RateTime to Healing
Conservative (acute)50-60%30-40% if risk factors persist4-6 weeks
GTN 0.4%49-68%30-50% within 1 year6-8 weeks
Diltiazem 2%65-75%30-40% within 1 year6-8 weeks
Botulinum toxin65-85%40-50% within 2 years8-12 weeks
Lateral internal sphincterotomy95-98%less than 5%6-8 weeks

Exam Detail: Cochrane Review Summary (Nelson et al., 2012): [7]

GTN vs placebo: NNT = 8 (need to treat 8 patients to heal one additional fissure beyond placebo) Medical therapy (any) vs surgery: Surgery significantly more effective (OR 5.5, 95% CI 3.4-8.7) Clinical implication: Medical therapy is acceptable first-line but surgery should be offered for failures

Prognostic Factors

Good Prognosis:

  • Acute fissure (first episode)
  • Posterior midline location
  • No previous fissure history
  • Addresses constipation and dietary risk factors
  • Good compliance with treatment
  • No underlying inflammatory bowel disease
  • Response to medical therapy

Poor Prognosis:

  • Chronic fissure (> 6-8 weeks)
  • Lateral or off-midline location (secondary cause likely)
  • Recurrent fissures
  • Underlying Crohn's disease (healing rates 50-60% even with optimal therapy)
  • Immunosuppression (HIV, chemotherapy)
  • Risk factors not addressed (persistent constipation)
  • Failed medical therapy
  • Previous failed surgery

Long-Term Outcomes

  • Post-LIS: > 90% remain healed at 5 years with appropriate lifestyle maintenance [11]
  • Incontinence post-LIS: Most minor incontinence resolves within 6-12 months; 2-3% have persistent symptoms
  • Quality of life: Significant improvement post-treatment; surgical patients report highest satisfaction despite incontinence risk

10. Evidence and Guidelines

Key Clinical Practice Guidelines

  1. American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines: Management of Anal Fissure (2023 update) [1]

    • Strong recommendation for conservative measures in all patients
    • Strong recommendation for topical GTN or calcium channel blockers as first-line medical therapy for chronic fissure
    • Strong recommendation for lateral internal sphincterotomy for medically refractory chronic fissure
    • Conditional recommendation for botulinum toxin for patients at high risk of incontinence
  2. Association of Coloproctology of Great Britain and Ireland (ACPGBI) [4]

    • Stepwise management approach endorsed
    • Emphasis on informed consent regarding incontinence with surgery
    • Tailored sphincterotomy recommended
  3. NICE Clinical Knowledge Summaries (CKS): Anal Fissure [19]

    • Primary care guidance on diagnosis and initial conservative management
    • Referral criteria for specialist care

Landmark Trials and Systematic Reviews

1. Cochrane Review: Non-surgical therapy for anal fissure (Nelson et al., 2012) [7]

  • 75 RCTs, 5,031 participants
  • GTN healed 48.9% vs 35.5% placebo (pless than 0.0009)
  • All medical therapies less effective than surgery
  • High recurrence rates with medical therapy
  • Clinical Impact: Established that medical therapy is marginally better than placebo; surgery remains most effective

2. Meta-analysis: Botulinum toxin vs lateral sphincterotomy (Sajid et al., 2012) [18]

  • LIS: 94.8% healing; Botox: 69.5% healing
  • Recurrence higher with Botox (25% vs 2%)
  • Similar incontinence rates
  • Clinical Impact: LIS remains gold standard but Botox viable alternative

3. Randomised trial: GTN vs placebo (Lund & Scholefield, 1997) [16]

  • First major RCT establishing GTN efficacy
  • 68% healing with GTN vs 8% placebo
  • Headache in 58% of GTN group
  • Clinical Impact: Established chemical sphincterotomy concept

4. Systematic review: Diltiazem vs GTN (Brisinda et al., 2007) [17]

  • Similar efficacy between agents
  • Diltiazem better tolerated (fewer headaches)
  • Clinical Impact: Diltiazem increasingly preferred first-line

Evidence Levels Summary

InterventionLevel of EvidenceRecommendation Strength
Conservative measures (fibre, fluids)Level IV (expert consensus)Strong recommendation
GTN/Diltiazem for chronic fissureLevel 1a (meta-analysis of RCTs)Strong recommendation
Botulinum toxin injectionLevel 1b (RCTs)Moderate recommendation
Lateral internal sphincterotomyLevel 1a (meta-analysis)Strong recommendation for refractory cases
Tailored vs full sphincterotomyLevel 2 (cohort studies)Conditional recommendation (tailored preferred)
Biopsy of non-healing fissureLevel V (expert opinion)Strong recommendation

11. Exam-Focused Content

Common Exam Questions

1. "What are the causes of anal fissure?"

Primary (Idiopathic):

  • Constipation and hard stool passage (most common)
  • Chronic diarrhoea (irritation)
  • Childbirth (particularly traumatic/instrumental)
  • Anal intercourse
  • Previous anal surgery

Secondary (Suspect if lateral/multiple/atypical):

  • Crohn's disease (most common secondary cause)
  • Ulcerative colitis (less common than Crohn's)
  • Tuberculosis
  • HIV/AIDS
  • Syphilis
  • Anal carcinoma
  • Leukaemia/lymphoma
  • Chemotherapy/immunosuppression

2. "Describe the pathophysiology of chronic anal fissure."

Model Answer: "The pathophysiology centres on a self-perpetuating cycle of trauma, pain, sphincter spasm, and ischaemia.

Initial trauma from hard stool passage causes a tear in the anoderm, typically at the posterior midline. The posterior commissure is vulnerable because it represents a watershed zone with terminal blood supply from the inferior rectal artery, receiving up to 85% less perfusion than lateral quadrants.

The tear causes severe pain, which triggers reflex spasm of the internal anal sphincter. This results in elevated resting anal pressure—studies show pressures of 90-120 mmHg compared to normal values of 40-70 mmHg.

The sustained sphincter hypertonia compresses intramural blood vessels, causing ischaemia at the already poorly perfused fissure base. This hypoxic wound environment prevents healing, and the exposed wound is re-traumatised with each defecation.

A chronic fissure develops with characteristic features: a deep ulcer with exposed internal sphincter fibres, a sentinel pile (skin tag) at the external margin, and a hypertrophied anal papilla proximally. Breaking this cycle through pharmacological or surgical sphincter relaxation is the key to treatment."

3. "How would you manage a patient with chronic anal fissure refractory to medical therapy?"

Model Answer: "For a patient with chronic anal fissure refractory to 8-12 weeks of optimal medical therapy (topical GTN or diltiazem plus conservative measures), I would:

First, confirm the diagnosis and exclude secondary causes—I would examine to confirm the fissure is in a typical location and consider investigations for Crohn's disease, HIV, or malignancy if atypical features are present. A non-healing fissure should have biopsy to exclude carcinoma.

Second, discuss treatment options with the patient:

Option 1: Botulinum toxin injection

  • Less invasive; can be performed in outpatient setting
  • 65-85% healing rate
  • Reversible; effect lasts 3-4 months
  • Higher recurrence than surgery (40-50%)
  • 5-10% temporary incontinence to flatus
  • Particularly suitable for patients concerned about permanent incontinence

Option 2: Lateral internal sphincterotomy

  • Gold standard surgery with 95-98% healing rate
  • Low recurrence (less than 5%)
  • Day case procedure
  • Risk of minor incontinence (flatus, soiling) in 8-12%
  • Risk of major incontinence in 1-3%

Pre-operative assessment would include detailed history (obstetric trauma, baseline continence), and I would consider endoanal ultrasound to assess sphincter integrity, particularly in women with obstetric history.

My recommendation for most patients would be lateral internal sphincterotomy given its superior efficacy and low recurrence. However, for patients at high risk of incontinence (multiparous women, prior sphincter injury, low resting pressure), I would offer botulinum toxin first.

I would counsel the patient thoroughly about the permanent incontinence risk with surgery and document informed consent."

Viva Points

Viva Point: Opening Statement: "Anal fissure is a longitudinal tear in the anoderm distal to the dentate line, most commonly occurring at the posterior midline due to the relatively ischaemic watershed blood supply in this region. It is one of the commonest anorectal conditions, affecting approximately 11% of the population, and is characterised by severe pain during defecation and bright red rectal bleeding."

Key Classification to State:

  • Acute (less than 6 weeks) vs Chronic (> 6-8 weeks with sentinel pile, exposed sphincter fibres, hypertrophied papilla)
  • Primary (posterior/anterior midline) vs Secondary (lateral, multiple—investigate for Crohn's, HIV, TB, malignancy)

Key Statistics to Cite:

  • 85-90% posterior midline (Klosterhalfen studies show 85% reduced blood flow at posterior commissure)
  • Medical therapy: 49-68% healing (GTN), 65-75% (diltiazem)
  • Lateral internal sphincterotomy: 95-98% healing, less than 5% recurrence
  • Incontinence risk post-LIS: 8-12% minor, 1-3% major

Key Evidence to Reference:

  • Cochrane review (Nelson 2012): 75 RCTs, GTN marginally better than placebo, all medical therapy less effective than surgery
  • ASCRS guidelines (2023): Stepwise approach, GTN/diltiazem first-line, LIS for failures

Common Mistakes to Avoid

Mistakes that fail candidates:

  1. Missing secondary causes: Not investigating a lateral or atypical fissure for Crohn's disease or malignancy
  2. Recommending surgery first-line: Most examiners expect stepwise approach (conservative → medical → surgical)
  3. Not counselling about incontinence: Failure to mention permanent incontinence risk with sphincterotomy
  4. Confusing IAS and EAS: The procedure divides the internal (smooth muscle, involuntary) sphincter, not the external
  5. Wrong posterior commissure anatomy: The posterior midline is ischaemic because of reduced blood supply, not increased tension
  6. Performing posterior sphincterotomy: Modern practice uses lateral approach to avoid keyhole deformity
  7. Missing the diagnosis in atypical presentations: Painless fissures, multiple fissures, or off-midline fissures
  8. Not examining high-risk patients before surgery: Missing pre-existing sphincter injury that increases incontinence risk

Model Answers

Q: A 35-year-old woman presents with severe anal pain during defecation for 3 months. On examination, you see a fissure at the left lateral position. What is your approach?

A: "A lateral fissure is atypical and should be considered secondary until proven otherwise. My immediate concern would be Crohn's disease, which is the commonest cause of lateral fissures.

My approach would be:

History: I would ask about gastrointestinal symptoms (abdominal pain, diarrhoea, weight loss), extra-intestinal manifestations of IBD (arthralgia, skin rashes, mouth ulcers), and any family history of inflammatory bowel disease. I would also enquire about HIV risk factors, TB exposure, and sexual history.

Examination: I would examine the perianal area for other features of Crohn's (multiple skin tags, fistulae, abscess), perform an abdominal examination, and look for extra-intestinal manifestations.

Investigations: I would arrange inflammatory markers (FBC, CRP), faecal calprotectin, HIV serology, and refer for colonoscopy with biopsies to exclude Crohn's disease. If the fissure has atypical features (indurated edges), I would biopsy it to exclude malignancy.

Management: I would initiate conservative treatment for the fissure while investigations are undertaken. Definitive management would depend on the underlying cause. If Crohn's disease is confirmed, I would involve the IBD team, and sphincterotomy would generally be avoided due to high failure rates and risk of non-healing wounds."


12. Special Populations

Pregnancy and Postpartum

  • Prevalence: Common during pregnancy (increased constipation) and postpartum (delivery trauma)
  • Location: Anterior fissures more common in postpartum women (up to 40%)
  • Management:
    • "First-line: Conservative measures (fibre, fluids, stool softeners)"
    • Topical lidocaine for analgesia
    • GTN and diltiazem generally avoided in pregnancy (limited safety data); may consider in third trimester or postpartum if essential
    • Surgery avoided during pregnancy unless emergency
    • "Postpartum: Standard management pathway; consider sphincter assessment before surgery if instrumental/traumatic delivery"

Elderly Patients

  • Considerations:
    • Higher incontinence risk with surgery (age-related sphincter weakness)
    • Pre-existing continence issues more common
    • Lower tolerance of headache from GTN
    • Polypharmacy considerations (nitrate interactions)
  • Management:
    • Favour conservative and medical management
    • Botulinum toxin may be preferred over surgery if refractory
    • If surgery required, consider more conservative/tailored sphincterotomy
    • Pre-operative manometry to assess baseline function

Immunocompromised Patients

HIV/AIDS:

  • Atypical presentations common; may be painless
  • Healing correlates with immune status and viral control
  • Optimise antiretroviral therapy
  • Avoid surgery if CD4 less than 200 (poor healing)
  • Consider opportunistic infections (CMV, HSV)—may need biopsy

Chemotherapy/Transplant:

  • Poor healing during active immunosuppression
  • High infection risk with surgery
  • Conservative management preferred
  • Timing of any surgery to coincide with immune recovery

Crohn's Disease

  • Key Principle: Treat underlying Crohn's first
  • Characteristics: Lateral/multiple fissures; associated fistulae; "elephant ear" skin tags
  • Management:
    • Medical therapy for Crohn's (immunomodulators, biologics)
    • Conservative fissure management
    • Avoid sphincterotomy (high failure rate 50%; risk of non-healing wound)
    • Botulinum toxin may be considered if Crohn's controlled
    • Often requires multidisciplinary approach with gastroenterology

13. Patient/Layperson Explanation

What is an Anal Fissure?

An anal fissure is a small tear or crack in the lining of the back passage (anus). It's a very common condition—about 1 in 10 people will experience one at some point in their lives. The tear usually happens when passing a hard or large stool. It causes intense pain during and after bowel movements, often described as "like passing broken glass," and you may notice small amounts of bright red blood on the toilet paper.

Why Does It Happen?

The tear usually occurs at the back of the anal opening, where the blood supply is naturally weaker. When the tear happens:

  1. It causes severe pain
  2. The muscle around the back passage goes into spasm to protect the area
  3. This spasm reduces blood flow even further
  4. The wound can't heal properly
  5. Each time you have a bowel movement, the wound opens again

This creates a vicious cycle. Common triggers include:

  • Constipation and hard stools
  • Straining on the toilet
  • Pregnancy and childbirth
  • Chronic diarrhoea
  • Sometimes, underlying conditions like Crohn's disease

How is it Diagnosed?

Your doctor can usually diagnose an anal fissure simply by hearing your symptoms and gently examining the area. Often the tear can be seen by carefully separating the buttocks. Because of the pain, more invasive examinations may not be possible initially.

How is it Treated?

For new (acute) fissures (less than 6 weeks): Most heal with simple measures:

  • Eating more fibre (fruits, vegetables, wholegrain foods)
  • Drinking plenty of water (2-3 litres daily)
  • Using stool softeners (Movicol, lactulose)
  • Taking warm baths after bowel movements (sitz baths)
  • Using pain relief before opening your bowels

For older (chronic) fissures (lasting more than 6-8 weeks): These usually need medication:

  • Ointments (GTN or diltiazem) applied twice daily for 6-8 weeks
  • These relax the muscle and improve blood flow to help healing
  • About 6-7 out of 10 people heal with these treatments

If medications don't work:

  • Botox injections into the muscle (temporary; 7-8 out of 10 heal)
  • Surgery (lateral sphincterotomy) — the most effective option (over 95% heal)

What About Surgery?

Surgery involves making a small cut in the muscle around the back passage to relax it permanently. It's very effective but does carry a small risk (about 1 in 10) of affecting your ability to control wind, and a very small risk (1-2 in 100) of affecting your ability to control your bowels. Your surgeon will discuss this carefully with you before any operation.

When Should I Seek Medical Help?

See your doctor if:

  • Pain is severe and not improving with home treatment
  • Bleeding is heavy or persistent
  • You notice a fissure in an unusual position (on the side rather than back)
  • You have other symptoms like weight loss, fever, or a change in bowel habits
  • You have Crohn's disease or are immunocompromised
  • Symptoms are not improving after 6-8 weeks of treatment

What Can I Do to Prevent It Coming Back?

  • Keep stools soft with a high-fibre diet (25-30g daily)
  • Drink plenty of fluids
  • Don't ignore the urge to have a bowel movement
  • Don't strain or spend too long on the toilet
  • Consider continued use of a stool softener if you're prone to constipation

14. References

Primary Guidelines

  1. Stewart DB Sr, Gaertner WB, Glasgow SC, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anal Fissures. Dis Colon Rectum. 2023;66(2):190-199. doi:10.1097/DCR.0000000000002664 [PMID: 36538662]

Systematic Reviews and Meta-Analyses

  1. Gerbasi L, Ashurst JV. Anal Fissures. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. [PMID: 30252319]

  2. Mapel DW, Schum M, Von Worley A. The epidemiology and treatment of anal fissures in a population-based cohort. BMC Gastroenterol. 2014;14:129. doi:10.1186/1471-230X-14-129 [PMID: 25048612]

  3. Cross KL, Massey EJ, Fowler AL, Monson JR; Association of Coloproctology of Great Britain and Ireland. The management of anal fissure: ACPGBI position statement. Colorectal Dis. 2008;10 Suppl 3:1-7. doi:10.1111/j.1463-1318.2008.01681.x [PMID: 18954306]

  4. Klosterhalfen B, Vogel P, Rixen H, Mittermayer C. Topography of the inferior rectal artery: a possible cause of chronic, primary anal fissure. Dis Colon Rectum. 1989;32(1):43-52. doi:10.1007/BF02554724 [PMID: 2910661]

  5. Schouten WR, Briel JW, Auwerda JJ. Relationship between anal pressure and anodermal blood flow. The vascular pathogenesis of anal fissures. Dis Colon Rectum. 1994;37(7):664-669. doi:10.1007/BF02054410 [PMID: 8026232]

  6. Nelson RL, Thomas K, Morgan J, Jones A. Non-surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;2012(2):CD003431. doi:10.1002/14651858.CD003431.pub3 [PMID: 22336789]

  7. Hananel N, Gordon PH. Lateral internal sphincterotomy for fissure-in-ano—revisited. Dis Colon Rectum. 1997;40(5):597-602. doi:10.1007/BF02055387 [PMID: 9152191]

  8. D'Haens G, Baert F, van Assche G, et al. Crohn's disease-related anal fissures: effectiveness of treatment with adalimumab. Inflamm Bowel Dis. 2013;19(3):E45-46. doi:10.1002/ibd.22826 [PMID: 22848054]

  9. Corby H, Donnelly VS, O'Herlihy C, O'Connell PR. Anal canal pressures are low in women with postpartum anal fissure. Br J Surg. 1997;84(1):86-88. doi:10.1002/bjs.1800840130 [PMID: 9043464]

  10. Ebinger SM, Hardt J, Warschkow R, et al. Operative and medical treatment of chronic anal fissure—a review and network meta-analysis of randomized controlled trials. J Gastroenterol. 2017;52(6):663-676. doi:10.1007/s00535-017-1335-0 [PMID: 28365855]

  11. Garg P, Garg M, Menon GR. Long-term continence disturbance after lateral internal sphincterotomy for chronic anal fissure: a systematic review and meta-analysis. Colorectal Dis. 2013;15(3):e104-117. doi:10.1111/codi.12108 [PMID: 23320551]

  12. Scholefield JH, Bock JU, Marla B, et al. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures. Gut. 2003;52(2):264-269. doi:10.1136/gut.52.2.264 [PMID: 12524410]

  13. Barrett WL, Callahan TD, Orkin BA. Perianal manifestations of human immunodeficiency virus infection: experience with 260 patients. Dis Colon Rectum. 1998;41(5):606-611. doi:10.1007/BF02235269 [PMID: 9593245]

  14. Gibbons CP, Read NW. Anal hypertonia in fissures: cause or effect? Br J Surg. 1986;73(6):443-445. doi:10.1002/bjs.1800730609 [PMID: 3719268]

  15. Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet. 1997;349(9044):11-14. doi:10.1016/S0140-6736(96)06090-4 [PMID: 8988115]

  16. Brisinda G, Cadeddu F, Brandara F, et al. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg. 2007;94(2):162-167. doi:10.1002/bjs.5514 [PMID: 17256808]

  17. Sajid MS, Vijaynagar B, Desai M, et al. Botulinum toxin vs glyceryl trinitrate for the medical management of chronic anal fissure: a meta-analysis. Colorectal Dis. 2008;10(6):541-546. doi:10.1111/j.1463-1318.2007.01388.x [PMID: 17868492]

  18. National Institute for Health and Care Excellence. Anal fissure. NICE Clinical Knowledge Summaries. 2020. https://cks.nice.org.uk/topics/anal-fissure/

  19. Perry WB, Dykes SL, Buie WD, Rafferty JF; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissures (3rd revision). Dis Colon Rectum. 2010;53(8):1110-1115. doi:10.1007/DCR.0b013e3181e23f43 [PMID: 20628269]

Additional Resources


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This content does not constitute medical advice for individual patients.

Evidence trail

This article contains inline citation markers, but the full bibliography has not yet been imported as a visible references section. The page is still tracked through the editorial review pipeline below.

Tracked citations
Inline citations present
Reviewed by
MedVellum Editorial Team
Review date
17 Jan 2026

All clinical claims sourced from PubMed

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

  • Anorectal Anatomy
  • Constipation

Differentials

Competing diagnoses and look-alikes to compare.

Consequences

Complications and downstream problems to keep in mind.

  • Anal Stenosis
  • Faecal Incontinence